Signed Aug 31, 2026
- Committed
- n/a
- Matures
- Sep 2029
- Agent
- Not stated
| Tranche | Size | Matures | Margin |
|---|---|---|---|
| Series A Senior Notes | n/a | Sep 2029 | n/a |
Master Note Purchase Agreement
CovenantTestedHeadroomLimit now
Tested otherHeadroom not yet measured1.50
Equity cure available.
The Company will not permit the Asset Coverage Ratio to be less than 150% at any time.Read the filing on sec.gov ↗
Tested quarterlyHeadroom not yet measured$440m
Equity cure available.
(i) $440,000,000 plus (ii) 25% of the aggregate net cash proceeds of all sales of Equity Interests of the Company and its subsidiaries after the Effective DateRead the filing on sec.gov ↗
Amendments
No amendments on file yet.
Report an error
Email [email protected].